Literature DB >> 18340452

Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues.

Guiyu Wang1, Xishan Wang, Shuhuai Wang, Hongtao Song, Haiming Sun, Weiguang Yuan, Bo Cao, Jing Bai, Songbin Fu.   

Abstract

BACKGROUND AND AIMS: Early detection and treatment of human colorectal cancers remain a challenge. Identification of new potential markers may help in the diagnosis of colorectal cancer.
MATERIALS AND METHODS: By comparative two-dimensional gel electrophoresis using extracts from colorectal tumor and adjacent normal tissues, we identified a calcium-binding protein, S100A11, which was highly expressed in colorectal cancer compared with adjacent normal tissues. We expanded our study in 89 clinical colorectal tumor samples to validate this finding and correlates S100A11 expression in human colorectal cancer tissues with various stages of the tumor by Western blotting and immunohistochemical staining.
RESULTS: We identified a calcium-binding protein, S100A11, which was highly expressed in colorectal cancer compared with adjacent normal tissues. S100A protein was expressed predominantly in the cytoplasm of normal tissue; however, it was expressed in both the nuclei and cytoplasm of colorectal cancer. S100A11 level in colorectal cancer tissue was increased following stage progression of the disease.
CONCLUSION: These findings suggest S100A11 could be helpful in the pathological study of colorectal cancer, especially for the classification of different stages in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18340452     DOI: 10.1007/s00384-008-0464-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  42 in total

1.  Effects of phosphorothioate anti-sense oligodeoxynucleotides on colorectal cancer cell growth and telomerase activity.

Authors:  Xi-Shan Wang; Kuan Wang; Xue Li; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

Review 2.  Molecular markers that predict response to colon cancer therapy.

Authors:  Farid E Ahmed
Journal:  Expert Rev Mol Diagn       Date:  2005-05       Impact factor: 5.225

Review 3.  [Mechanisms of metastasis and molecular markers of malignant tumor progression. I. Colorectal cancer].

Authors:  Maciej S Wideł; Maria Wideł
Journal:  Postepy Hig Med Dosw (Online)       Date:  2006       Impact factor: 0.270

4.  Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy.

Authors:  Fraser M Smith; William M Gallagher; Edward Fox; Richard B Stephens; Elton Rexhepaj; Emanuel F Petricoin; Lance Liotta; M John Kennedy; John V Reynolds
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

Review 5.  Preoperative imaging staging of rectal cancer.

Authors:  A H Karantanas; S Yarmenitis; N Papanikolaou; N Gourtsoyiannis
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

Review 6.  Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence.

Authors:  I R Daniels; S E Fisher; R J Heald; B J Moran
Journal:  Colorectal Dis       Date:  2007-05       Impact factor: 3.788

Review 7.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

8.  Human S100A11 exhibits differential steady-state RNA levels in various tissues and a distinct subcellular localization.

Authors:  H Inada; M Naka; T Tanaka; G E Davey; C W Heizmann
Journal:  Biochem Biophys Res Commun       Date:  1999-09-16       Impact factor: 3.575

Review 9.  Chemoprevention of colorectal cancer with cyclooxygenase-2 inhibitors: two steps forward, one step back.

Authors:  Monica M Bertagnolli
Journal:  Lancet Oncol       Date:  2007-05       Impact factor: 41.316

Review 10.  Current treatment strategies in elderly patients with metastatic colorectal cancer.

Authors:  Hendrik-Tobias Arkenau; Yu Jo Chua; David Cunningham
Journal:  Clin Colorectal Cancer       Date:  2007-05       Impact factor: 4.481

View more
  16 in total

1.  Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics.

Authors:  Alexandre Dos Santos; Magali Court; Valérie Thiers; Sokhavuth Sar; Catherine Guettier; Didier Samuel; Christian Bréchot; Jérôme Garin; France Demaugre; Christophe D Masselon
Journal:  Mol Cell Proteomics       Date:  2010-05-31       Impact factor: 5.911

2.  Large-scale proteomic identification of S100 proteins in breast cancer tissues.

Authors:  Patrizia Cancemi; Gianluca Di Cara; Nadia Ninfa Albanese; Francesca Costantini; Maria Rita Marabeti; Rosa Musso; Carmelo Lupo; Elena Roz; Ida Pucci-Minafra
Journal:  BMC Cancer       Date:  2010-09-03       Impact factor: 4.430

3.  De Novo proteome analysis of genetically modified tumor cells by a metabolic labeling/azide-alkyne cycloaddition approach.

Authors:  Seda Ballikaya; Jennifer Lee; Uwe Warnken; Martina Schnölzer; Johannes Gebert; Jürgen Kopitz
Journal:  Mol Cell Proteomics       Date:  2014-09-15       Impact factor: 5.911

Review 4.  S100 protein family in human cancer.

Authors:  Hongyan Chen; Chengshan Xu; Qing'e Jin; Zhihua Liu
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

5.  ELK1‑mediated upregulation of lncRNA LBX2‑AS1 facilitates cell proliferation and invasion via regulating miR‑491‑5p/S100A11 axis in colorectal cancer.

Authors:  Gang Ma; Weijie Dai; Juan Zhang; Qianjun Li; Biao Gu; Yaqi Song; Xiaozhong Yang
Journal:  Int J Mol Med       Date:  2021-06-03       Impact factor: 4.101

6.  S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.

Authors:  Claudia Maletzki; Peggy Bodammer; Anne Breitrück; Claus Kerkhoff
Journal:  Hepat Mon       Date:  2012-10-12       Impact factor: 0.660

Review 7.  Metastasis: new perspectives on an old problem.

Authors:  Sandra Kraljevic Pavelic; Mirela Sedic; Hrvojka Bosnjak; Sime Spaventi; Kresimir Pavelic
Journal:  Mol Cancer       Date:  2011-02-22       Impact factor: 27.401

8.  Identification of Protein Markers Specific for Papillary Renal Cell Carcinoma Using Imaging Mass Spectrometry.

Authors:  Chan Hyun Na; Ji Hye Hong; Wan Sup Kim; Selina Rahman Shanta; Joo Yong Bang; Dongmin Park; Hark Kyun Kim; Kwang Pyo Kim
Journal:  Mol Cells       Date:  2015-06-10       Impact factor: 5.034

9.  Up-Regulation of S100A11 in Lung Adenocarcinoma - Its Potential Relationship with Cancer Progression.

Authors:  Tetsukan Woo; Koji Okudela; Hideaki Mitsui; Michihiko Tajiri; Yasushi Rino; Kenichi Ohashi; Munetaka Masuda
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

10.  LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFβ/Smad signaling.

Authors:  Ya Niu; Ziyun Shao; Hui Wang; Jiaqi Yang; Feifei Zhang; Yuhao Luo; Lijun Xu; Yanqing Ding; Liang Zhao
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.